Diabetes Type 3

Please select from the menu above


Anecdotal observations by John Thomas

Return to Glossary
Go to Programs & Protocols
Special Insights Archive
Go to Home Page

Diabetes Type 3 describes a condition brought on by pre-diabetes; a state of being where the body is under assault and physiological stress because of mycotoxins produced by fungus, and  insulin and leptin resistance characterized by formation of plaque and varnishes on leptin receptors of the brain.

Overview

Type 3 is not true diabetes like type 1 and 2, but the name is appropriate for describing the progressive nature of the condition that manifests as cognitive issues such as, brain fog and poor memory in the early stages and senality, Alzherimer’s, Huntington’s and Parkinson’s in many cases.

Like it cousins, diabetes type 1 and 2, diabetes type 3 has everything to do with lifestyle and diet and nothing to do with one’s genes or DNA.

There is, however, a DNA connection that develops when fungal DNA merges with human DNA, the product of such a merger is a HYBIRD, part human and part fungus,  This merger is not responable for onset of diabetes, but it influences body metabolism and organ functions by way of mycotoxins produced by fungi.

Type 3 diabetes is a forerunner of hundreds of sub-clinical, symptomatic health complaints that fall short of type 1 and 2 diabetes; common health complaints that are degenerative in nature, such as arthritis, gout, obesity, etc.

Type 3 diabetes is characterized by chronic, low-grade, systemic inflammation and progressively dysfunctional brain receptor deterioration due to plaque and varnish formation and a progressively dysfunctional pancreas.

See, Pre-diaetes in Glossary by clicking link.

Read Special Insights, Pre-Diabetes & Aging in Archive link below, as well as, Change Your Food Habits, Change Your Life by clicking hyperlinks.

Suggestions

  1. Change your lifestyle and your diet.
  2. Embrace Young Again Club Protocols.
  3. Ask for help and be open to new ideas.

Return to Glossary
Go to Programs & Protocols
Special Insights Archive
Go to Home Page